IL17A and neoplasm: In an azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced cancer-associated colitis model, complement deficiency was shown to inhibit intestinal IL-1β production by neutrophils and IL-17A production by myeloid cells, and to repress tumor formation [164].